Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England
British Journal of Haematology · 2025
DOI: 10.1111/bjh.19907 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von David A Jones und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Population Health, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Lymphoma, Clinical Trials as Topic, Healthcare Disparities, Patient Selection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Oxford Biomedical Research Centre, National Institute for Health and Care Research, Cancer Research UK.
Abstract (Originalsprache)
The distribution of trial site locations may lead to disparities in geographic access and affect patient representativeness in clinical trials. We utilised trial data covering 1993–2022 from the National Institute for Health and Care Research (NIHR) Open Data Platform, 2011 and 2021 English Census and geographic data and English individual‐patient cancer registry data for patients diagnosed with lymphoma between 1997 and 2017. To assess representation, we compared patient age and sex between trial participants and the incident population. We mapped the distance and travel times of English lower layer super output areas (LSOAs) to their nearest research active NHS Trusts and assessed associations between distance and travel times and the geographic and sociodemographic characteristics of the LSOAs. Trial participants were younger than the incident population and more likely to be male. The closest NHS Trust to more than half of English LSOAs was not research active. Greater LSOA mean age, male percent, White British percent, rurality and coastal/border status were positively associated with distance and travel time (at prespecified p < 0.05 level), while greater deprivation was negatively associated. Female and older lymphoma patients in England are underrepresented in trials, with the latter facing a higher burden of geographic barriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nuffield Department of Population Health, University of Oxford, Oxford, UK.
- Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
- Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
- National Disease Registration Service, NHS England, Birmingham, UK.
- Bristol, UK.
ORCID-Profile: David A Jones
Förderung
- NIHR Oxford Biomedical Research Centre
- National Institute for Health and Care Research
- Cancer Research UK
Zitieren
APA
Jones, D. A., Spencer, K., Ramroth, J., Probert, J., Roope, L. S. J., Shakir, R., Broggio, J., Burroughs, F., Collins, G. P., Clarke, P. M., Wolstenholme, J. L., & Cutter, D. J. (2025). Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England. British Journal of Haematology. https://doi.org/10.1111/bjh.19907
Vancouver
Jones DA, Spencer K, Ramroth J, Probert J, Roope LSJ, Shakir R, et al. Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England. British Journal of Haematology. 2025. doi:10.1111/bjh.19907
BibTeX
@article{Jones2025,
author = {Jones, David A and Spencer, Katie and Ramroth, Johanna and Probert, Jake and Roope, Laurence S J and Shakir, Rebecca and Broggio, John and Burroughs, Frank and Collins, Graham P and Clarke, Philip M and Wolstenholme, Jane L and Cutter, David J},
title = {Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.19907}
}
EUVIMED